Intratumoral genomic heterogeneity in advanced head and neck cancer detected by comparative genomic hybridization

Advances in Oto-Rhino-Laryngology

Volumn 62, Issue , 2005, Pages 38-48

  Götte, Karl ^a   Tremmel, Susanne C ^b   Popp, Susanne ^b,c   Weber, Susanne ^b   Hörmann, Karl ^a   Bartram, Claus R ^b   Jauch, Anna ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

AGED; ALLELIC IMBALANCE; ARTICLE; CANCER STAGING; CHROMOSOME 11; CHROMOSOME 3; CHROMOSOME 9; COMPARATIVE STUDY; EPIDEMIOLOGY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETIC MARKER; GENETICS; GENOME; HEAD AND NECK TUMOR; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

AGED; ALLELIC IMBALANCE; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 9; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENETIC MARKERS; GENOME; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; PROGNOSIS; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 16644361805     PISSN: 00653071     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (56)

1. Jin Y, Mertens F, Mandahl N, Heim S, Olegard C, Wennerberg J, Biörklund A, Mitelman F: Chromosome abnormalities in eighty-three head and neck squamous cell carcinomas: Influence of culture conditions on karyotypic pattern. Cancer Res 1993;53:2140-2146.
2. Jin Y, Mertens F, Jin C, Akervall J, Wennerberg J, Gorunova L, Mandahl N, Heim S, Mitelman F: Nonrandom chromosome abnormalities in short-term cultured primary squamous cell carcinomas of the head and neck. Cancer Res 1995;55:3204-3210.
3. Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT, Drumheller T, Tilley BC, Carey TE: Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer 1994;3:192-206.
4. Nowell PC: The clonal evolution of tumor cell populations. Science 1976;194:23-28.
5. Nowell PC: Chromosomal and molecular clues to tumor progression. Semin Oncol 1989;16:116-127.
6. Slaugther DP, Southwick HW Smejkal W: 'Field cancerization' in oral stratified squamous epithelium. Cancer 1953;6:963-968.
7. Carey TE, Van Dyke DL, Worsham MJ: Nonrandom chromosomes aberrations and clonal populations in head and neck cancer. Anticancer Res 1993;13:2561-2568.
8. Soder AI, Hopman AH, Ramaekers FC, Conradt C, Bosch FX: Distinct nonrandom patterns of chromosomal aberrations in the progression of squamous cell carcinomas of the head and neck. Cancer Res 1995;55:5030-5037.
9. Speicher MR, Howe C, Crotty P, du Manoir S, Costa J, Ward DC: Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 1995;55:1010-1013.
10. Brzoska PM, Levin NA, Fu KK, Kaplan MJ, Singer MI, Gray JW, Christman MF: Frequent novel DNA copy number increase in squamous cell head and neck tumors. Cancer Res 1995;55:3055-3059.
11. Bockmühl U, Schwendel A, Dietel M, Petersen I: Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res 1996;56:5325-5329.
12. Bockmühl U, Petersen S, Schmidt S, Wolf G, Jahnke V, Dietel M, Petersen I: Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res 1997;57:5213-5216.
13. Bockmühl U, Wolf G, Schmidt S, Schwendel A, Jahnke V, Dietel M, Petersen I: Genomic alterations associated with malignancy in head and neck cancer. Head Neck 1998;20:145-151.
14. Weber RG, Scheer M, Born IA, Joos S, Cobbers JM, Hofele C, Reifenberger G, Zoller JE, Lichter P: Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization. Am J Pathol 1998;153:295-303.
15. Bergamo NA, Rogatto SR, Poli-Frederico RC, Reis PP, Kowalski LP, Zielenska M, Squire JA: Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7p, and 8q in head and neck carcinomas. Cancer Genet Cytogenet 2000;119:48-55.
16. Hermsen MA, Joenje H, Arwert F, Braakhuis BJ, Baak JP, Westerveld A, Slater R: Assessment of chromosomal gains and losses in oral squamous cell carcinoma by comparative genomic hybridisation. Oral Oncol 1997;33:414-418.
17. Oga A, Kong G, Tae K, Lee Y, Sasaki K: Comparative genomic hybridization analysis reveals 3q gain resulting in genetic alteration in 3q in advanced oral squamous cell carcinoma. Cancer Genet Cytogenet 2001;127:24-29.
18. Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, Lazarus P, Schäffer AA, Desper R, Schantz SP: Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: Construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 2002;34:224-233.
19. Welkoborsky HJ, Bernauer HS, Riazimand HS, Jacob R, Mann WJ, Hinni ML: Patterns of chromosomal aberrations in metastasizing and nonmetastasizing squamous cell carcinomas of the oropharynx and hypopharynx. Ann Otol Rhinol Laryngol 2000;109:401-410.
20. Bockmühl U, Schluns K, Schmidt S, Matthias S, Petersen I: Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Genes Chromosomes Cancer 2002;33:29-35.
21. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al (eds): American Joint Committee on Cancer Staging Manual, ed 5. Philadelphia, Lippincott-Raven, 1997.
22. Telenius H, Pelmear AH, Tunnacliffe A, Carter NP, Behmel A, Ferguson-Smith MA, Nordenskjold M, Pfragner R, Ponder BA: Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes Cancer 1992;4:257-263.
23. Du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Döhner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T: Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 1993;90:590-610.
24. Waldman FM, DeVries S, Chew KL, Moore DH II, Kerlikowske K, Ljung BM: Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J Natl Cancer Inst 2000;92:313-320.
25. Forastiere A, Koch W, Trotti A, Sidransky D: Head and neck cancer. N Engl J Med 2001;345:1890-1900.
26. Gollin SM: Chromosomal alterations in squamous cell carcinomas of the head and neck: Window to the biology of disease. Head Neck 2001;23:238-253.
27. Crowe DL, Hacia JG, Hsieh CL, Sinha UK, Rice H: Molecular pathology of head and neck cancer. Histol Histopathol 2002;17:909-914.
28. Sun PC, el-Mofty SK, Haughey BH, Scholnick SB: Allelic loss in squamous cell carcinomas of the larynx: Discordance between primary and metastatic tumors. Genes Chromosomes Cancer 1995;14:145-148.
29. Leong PP, Rezai B, Koch WM, Reed A, Eisele D, Lee DJ, Sidransky D, Jen J, Westra WH: Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst 1998;90:972-977.
30. Takes RP, Baatenburg de Jong RJ, Wijffels K, Schuuring E, Litvinov SV, Hermans J, van Krieken JH: Expression of genetic markers in lymph node metastases compared with their primary tumors in head and neck cancer. J Pathol 2001;194:298-302.
31. Götte K, Riedel F, Schäfer C, Coy JF, Hörmann K: Genetic discordance between primary tumors and metastases of head and neck cancer detected by microsatellite analysis. Oncol Rep 2002;9:829-834.
32. Tabor MP, van Houten VM, Kummer JA, Vosjan MJ, Vlasblom R, Snow GB, Leemans CR, Braakhuis BJ, Brakenhoff RH: Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene. Genes Chromosomes Cancer 2002;33:168-177.
33. El-Naggar AK, Lopez-Varela V, Luna MA, Weber R, Batsakis JG: Intratumoral DNA content heterogeneity in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1992;118:169-173.
34. El-Naggar AK, Hurr K, Luna MA, Goepfert H, Hong WK, Batsakis JG: Intratumoral genetic heterogeneity in primary head and neck squamous carcinoma using microsatellite markers. Diagn Mol Pathol 1997;6:305-308.
35. Bockmühl U, Schmidt S, Petersen S, Petersen I: Deletionen des Chromosoms 10q - Marker für die Metastasierung bei Kopf-Hals-Karzinomen? Laryngorhinootologie 2000;79:81-85.
36. Hermsen M, Guervos MA, Meijer G, Baak J, van Diest P, Marcos CA, Sampedro A: New chromosomal regions with high-level amplifications in squamous cell carcinomas of the larynx and pharynx, identified by comparative genomic hybridization. J Pathol 2001;194:177-182.
37. Wolff E, Girod S, Liehr T, Vorderwülbecke U, Ries J, Steininger H, Gebhart E: Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridisation. Oral Oncol 1998;34:186-190.
38. Singh B, Stoffel A, Gogineni S, Poluri A, Pfister DG, Shaha AR, Pathak A, Bosl G, Cordon-Cardo C, Shah JP, Rao PH: Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. Am J Pathol 2002;161:365-371.
39. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW: PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 1999;21:99-102.
40. Ma YY, Wei SJ, Lin YC, Lung JC, Chang TC, Whang-Peng J, Liu JM, Yang DM, Yang WK, Shen CY: PIK3CA as an oncogene in cervical cancer. Oncogene 2000;19:2739-2744.
41. Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, Ratovitski EA, Jen J, Sidransky D: AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 2000;97:5462-5467.
42. Yamaguchi K, Wu L, Caballero OL, Hibi K, Trink B, Resto V, Cairns P, Okami K, Koch WM, Sidransky D, Jen J: Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma. Int J Cancer 2000;86:684-689.
43. 1 overexpression. Cancer 1997;79:380-389.
44. 1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 2002;112:472-481.
45. Rodrigo JP, Gonzalez MV, Lazo PS, Ramos S, Coto E, Alvarez I, Garcia LA, Suarez C: Genetic alterations in squamous cell carcinomas of the hypopharynx with correlations to clinicopathological features. Oral Oncol 2002;38:357-363.
46. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J, Sidransky D: High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996;56:3630-3633.
47. Nunn J, Scholes AG, Liloglou T, Nagini S, Jones AS, Vaughan ED, Gosney JR, Rogers S, Fear S, Field JK: Fractional allele loss indicates distinct genetic populations in the development of squamous cell carcinoma of the head and neck (SCCHN). Carcinogenesis 1999;20:2219-2228.
48. Bazan V, Zanna I, Migliavacca M, Sanz-Casla MT, Maestro ML, Corsale S, Macaluso M, Dardanoni G, Restivo S, Quintela PL, Bernaldez R, Salerno S, Morello V, Tomasino RM, Gebbia N, Russo A: Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma. J Cell Physiol 2002;192:286-293.
49. Knuutila S, Aalto Y, Autio K, Björkqvist AM, El-Rifai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S, Larramendy ML, Lushnikova T, Monni O, Pere H, Tapper J, Tarkkanen M, Varis A, Wasenius VM, Wolf M, Zhu Y: DNA copy number losses in human neoplasms. Am J Pathol 1999;155:683-694.
50. Piccinin S, Gasparotto D, Vukosavljevic T, Barzan L, Sulfaro S, Maestro R, Boiocchi M: Microsatellite instability in squamous cell carcinomas of the head and neck related to field cancerization phenomena. Br J Cancer 1998;78:1147-1151.
51. Partridge M, Emilion G, Pateromichelakis S, Phillips E, Langdon J: Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas. Int J Cancer 1999;83:318-325.
52. Pateromichelakis S, Lee G, Langdon JD, Partridge M: The FHIT gene in oral squamous cell carcinoma: Allelic imbalance is frequent but cDNA aberrations are uncommon. Oral Oncol 2000;36:180-188.
53. Hogg RP, Honorio S, Martinez A, Agathanggelou A, Dallol A, Fullwood P, Weichselbaum R, Kuo MJ, Maher ER, Latif F: Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma. Eur J Cancer 2002;38:1585-1592.
54. Van den Brekel MW, Balm AJ: Editorial comment on 'Frequent 3p allele loss and epigenetic inactivation of the RASSFIA tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma' by Hogg and colleagues. Eur J Cancer 2002;38:1561-1563.
55. Petersen I, Hidalgo A, Petersen S, Schluns K, Schewe C, Pacyna-Gengelbach M, Goeze A, Krebber B, Knosel T, Kaufmann O, Szymas J, von Deimling A: Chromosomal imbalances in brain metastases of solid tumors. Brain Pathol 2000;10:395-401.
56. Jin C, Jin Y, Wennerberg J, Akervall J, Dictor M, Mertens F: Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck. Cancer Genet Cytogenet 2002;132:85-96.